CeriBell Inc (CBLL)
CeriBell, Inc. is a U.S.-based medical technology company focused on acute-care EEG solutions. Its Ceribell System is a point-of-care EEG platform designed to help address unmet needs in hospital and emergency settings. The company’s product lineup includes disposable flexible headbands and headcaps, a pocket-sized rechargeable recorder that captures and wirelessly transmits EEG signals, and Clarity, an AI-powered seizure detection algorithm. CeriBell also operates an EEG portal that provides real-time remote access to patient EEG data. Founded in 2014 and formerly known as Brain Stethoscope, Inc., the company adopted its current name in 2015 and is headquartered in Sunnyvale, California. The listed security is common stock on the NASDAQ exchange.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-CBLL
|
$17.29
|
-29.0% Downside
|
Overvalued
|
$28
|
14.9% Upside
|
Fair
|
Good
|
0.0%
|
November 17, 2026
|
7.3x
|
9.2x
|
935.3 M
|
827.9 M
|
2.2%
|
69.1%
|
13.2
|
85.0%
|
